© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Aspen Pharmacare Holdings Limited (APNHY) stock remained unchanged at $8.82 a share on OTC. The stock opened at $8.63, fluctuating between $8.63 to $8.82 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 08, 2026 | 8.82 | 8.82 | 8.82 | 8.82 | 1.51K |
| Apr 28, 2026 | 8.40 | 8.40 | 8.40 | 8.40 | 202 |
| Apr 23, 2026 | 8.34 | 8.47 | 8.34 | 8.47 | 1.25K |
| Apr 14, 2026 | 8.00 | 8.00 | 8.00 | 8.00 | 1.03K |
| Apr 13, 2026 | 8.04 | 8.15 | 8.04 | 8.15 | 700 |
| Apr 10, 2026 | 8.31 | 8.31 | 8.31 | 8.31 | 268 |
| Apr 09, 2026 | 8.09 | 8.09 | 8.09 | 8.09 | 591 |
| Apr 06, 2026 | 8.17 | 8.17 | 7.90 | 7.90 | 585 |
| Apr 01, 2026 | 7.87 | 7.87 | 7.87 | 7.87 | 5 |
| Mar 31, 2026 | 7.77 | 7.77 | 7.77 | 7.77 | 7 |
| Mar 24, 2026 | 7.64 | 7.64 | 7.64 | 7.64 | 480 |
| Mar 23, 2026 | 7.50 | 7.50 | 7.50 | 7.50 | 172 |
| Mar 13, 2026 | 7.89 | 7.90 | 7.89 | 7.90 | 690 |
| Mar 10, 2026 | 8.86 | 8.86 | 8.86 | 8.86 | 258 |
| Mar 09, 2026 | 8.40 | 8.61 | 8.40 | 8.61 | 386 |
| Mar 03, 2026 | 8.33 | 8.33 | 8.33 | 8.33 | 566 |
| Mar 02, 2026 | 8.34 | 8.34 | 8.34 | 8.34 | 278 |
| Feb 25, 2026 | 8.37 | 8.37 | 8.37 | 8.37 | 359 |
| Feb 24, 2026 | 8.05 | 8.05 | 8.05 | 8.05 | 534 |
| Feb 23, 2026 | 7.82 | 7.82 | 7.82 | 7.82 | 39 |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
| Employees | 8867 |
| Beta | 0.35 |
| Sales or Revenue | $43.36B |
| 5Y Sales Change% | 0.154% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |